Harold O'Brien
Psychiatric/Mental Health · Louisville, KYNPI 1003127358
Payments from drug & device makers
Across 843 payments — averaging $32.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$19K
- Takeda Pharmaceuticals U.S.A., Inc.$1K
- Otsuka America Pharmaceutical, Inc.$890
- Neos Therapeutics, LP$729
- Corium, LLC$722
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$694
- plus $5K from 26 others
What the payments were for
- Speaking & faculty fees$14,85054%
- Travel & lodging$1,6686%
- Food & beverage$11,03040%
- Education$220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 223 | $18,922 |
| Takeda Pharmaceuticals U.S.A., Inc. | 82 | $1,096 |
| Otsuka America Pharmaceutical, Inc. | 74 | $890 |
| Neos Therapeutics, LP | 86 | $729 |
| Corium, LLC | 60 | $722 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 43 | $694 |
| Johnson & Johnson | 33 | $569 |
| Lundbeck LLC | 35 | $550 |
| Noven Therapeutics, LLC | 31 | $508 |
| Alkermes, Inc. | 31 | $500 |
| Ironshore Pharmaceuticals Inc. | 30 | $440 |
| Axsome Therapeutics, Inc. | 25 | $404 |
| Vanda Pharmaceuticals Inc. | 14 | $288 |
| Tris Pharma Inc | 11 | $177 |
| Almatica Pharma LLC | 7 | $113 |
| Supernus Pharmaceuticals, Inc. | 7 | $106 |
| Idorsia Pharmaceuticals US Inc | 6 | $103 |
| Merck | 5 | $99 |
| Sunovion Pharmaceuticals Inc. | 5 | $97 |
| Adlon Therapeutics L.p. | 7 | $94 |
| Avanir Pharmaceuticals, Inc. | 5 | $83 |
| Teva Pharmaceuticals USA, Inc. | 4 | $69 |
| Bausch Health US, LLC | 3 | $61 |
| Collegium Pharmaceutical, Inc. | 3 | $60 |
| Vertical Pharmaceuticals, LLC | 3 | $40 |
| Neurocrine Biosciences, Inc. | 2 | $37 |
| Alfasigma USA, Inc. | 2 | $30 |
| Jazz Pharmaceuticals Inc. | 2 | $28 |
| OWP Pharmaceuticals, Inc. | 1 | $21 |
| Neuronetics, Inc. | 1 | $16 |
| Aytu Biopharma, Inc. | 1 | $12 |
| Eisai Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$16,558
How this compares
$27,570 in reported general payments places this provider in the 95th percentile of 946 psychiatric/mental health providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abilify MaintenaAripiprazole | 11 | $30,520 |
| TrintellixVortioxetine Hydrobromide | 16 | $15,178 |
| VyvanseLisdexamfetamine Dimesylate | 17 | $6,511 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 34 | $3,975 |
| Bupropion XlBupropion Hcl | 28 | $2,409 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 39 | $986 |
| Buprenorphine Hcl | 17 | $921 |
| Ziprasidone Hcl | 11 | $614 |
| Methylphenidate Hcl | 28 | $605 |
| Gabapentin | 23 | $441 |
| Aripiprazole | 13 | $397 |
| Haloperidol | 12 | $366 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 12 | $357 |
| Clonazepam | 33 | $305 |
| Buspirone Hcl | 16 | $302 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Abilify Maintena | $890 | $30,52011 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $1,096 | $21,68933 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 946 psychiatric/mental health providers in Kentucky.
Other psychiatric/mental health in Louisville
- Denise de AngelisLouisville$384K
- Mark BushLouisville$52K
- Shane WattsLouisville$13K
- Clinton RayhillLouisville$9K
- Michelle LoseLouisville$7K
- Ryan HopsonLouisville$7K
- Kimberly ViltLouisville$7K
- Theresa WattsAshland$645K
- Rachel ColeHopkinsville$503K
- Jennifer SampangCrestview Hills$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.